Conflict of interest
Cancer
CANCER
FMM is medical advisor for NanoMab Technology Ltd. and Advanced Accelerator Applications (AAA) GmbH/Novartis; holds speaker positions at Siemens, GE Healthcare, and Bayer; and has recently received institutional grants from NanoMab Technology Ltd., Siemens, and GE Precision Healthcare LLC. FMM is supported by the German Research Foundation (DFG) within the framework of the Research Training Group 2375 “Tumor-targeted Drug Delivery” (grant 331065168), the Clinical Research Unit CRU 5011 “Integrating emerging methods to advance translational kidney research (InteraKD)” (project 445703531), and the Research Unit 2591 “Severity assessment in animal-based research” (project 321137804). In addition, his research is funded by German Cancer Aid (projects 70113779 and 70113780) and the German Federal Ministry of Research and Education (project 16GW0319K).K.-J.L and F.M.M. received honoraria for consultancy service from Telix Pharmaceuticals. P.L. received speaker honoraria from Blue Earth Diagnostics. N.G. received honoraria for lectures from Blue Earth Diagnostics and honoraria for advisory board participation from Telix Pharmaceuticals.